Cargando…
Endocrine risk factors for COVID-19: Endogenous and exogenous glucocorticoid excess
Patients with endogenous or exogenous glucocorticoid (GC) excess exhibit a range of side effects, including an increased risk of infections. Via both mechanism, immune impairments and cardiometabolic concomitant diseases, patients with GC excess could be at increased risk for COVID-19. The impact on...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267234/ https://www.ncbi.nlm.nih.gov/pubmed/34241765 http://dx.doi.org/10.1007/s11154-021-09670-0 |